← Insider buys
ADAP

Adaptimmune Therapeutics Plc · HEALTHCARE

Director Peter A. Thompson sold $2.3M of Adaptimmune Therapeutics Plc

Sold$2,310,420
$13.51Price
171,000Shares
−3%Stake

What ADAP did after the filing

Prices for ADAP after this filing aren't in yet.

Traded Wed, May 30. Filed Fri, Jun 1, 5:27 PM ET, after the close. Not investment advice.